Enlivex ENLV
NASDAQ ENLV
$1.50 -0.23 (-13.29%)
At close: Aug 20, 2026 · 4:00 PM EDT

Enlivex (ENLV) Receivables - Other (2016 - 2025)

Enlivex (ENLV) posted quarterly Receivables - Other of $235000.0 for Q4 2025, down 80.96% year-over-year from $1.2 million in Q4 2024, and down 73.6% quarter-over-quarter from $890000.0 in Q2 2025.

Enlivex (ENLV) Receivables - Other (2016 - 2025) Analysis & Trends

Enlivex's Receivables - Other history runs 9 years deep, the most recent figure standing at $235000.0 for Q4 2025.

  • In Q4 2025, Receivables - Other fell 80.96% year-over-year to $235000.0; the TTM figure through Dec 2025 stood at $235000.0 (down 80.96% YoY), while the FY2025 annual figure was $235000.0, down 80.96% from the prior year.
  • Receivables - Other for Q4 2025 stood at $235000.0, down from $890000.0 in the prior quarter.
  • The five-year high for Receivables - Other was $1.2 million in Q4 2024, with the low at $113000.0 in Q4 2023.
  • The 4-year median for Receivables - Other is $562500.0 (2025), against an average of $582500.0.
  • The sharpest annual moves came in 2024 and 2025: Receivables - Other soared 992.04% in 2024, then slumped 80.96% in 2025.
  • Enlivex's Receivables - Other stood at $125000.0 in 2022, then dropped by 9.6% to $113000.0 in 2023, then jumped by 992.04% to $1.2 million in 2024, then plunged by 80.96% to $235000.0 in 2025.
  • Business Quant data shows ENLV's Receivables - Other at $235000.0 in Q4 2025, $890000.0 in Q2 2025, and $1.2 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 Enlivex 4.58 Mn -1.17 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 235,000.00
Dec 31, 2025 235,000.00
Jun 30, 2025 890,000.00
Jun 30, 2025 890,000.00
Dec 31, 2024 1.23 Mn
Dec 31, 2024 1.23 Mn
Jun 30, 2024 898,000.00
Jun 30, 2024 898,000.00
Dec 31, 2023 113,000.00
Dec 31, 2023 113,000.00
Dec 31, 2022 125,000.00
Dec 31, 2022 125,000.00
Sep 30, 2020 1.69 Mn
Sep 30, 2020 1.69 Mn
Jun 30, 2020 1.64 Mn
Jun 30, 2020 1.64 Mn
Mar 31, 2020 1.78 Mn
Mar 31, 2020 1.78 Mn
Dec 31, 2019 403,000.00
Dec 31, 2019 403,000.00